Skip to main content

Find Clinical Trials

Home
Conditions
Gastroesophageal Reflux Disease

Clinical trial condition

Gastroesophageal Reflux Disease

Explore clinical trials studying Gastroesophageal Reflux Disease. Study availability and eligibility vary by location and protocol.

206 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Gastroesophageal Reflux Disease trial results

Completed

A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)

NCT00734097

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +8 more
Locations: Research Site Buenos Aires, Argentina

Research Site Santiago, Chile

Research Site Temuco, Chile

Research Site Viña del Mar, Chile

View Trial Details

Completed

Do Acid Sensing Ion Channels Contribute to Heartburn?

NCT01095133

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +8 more
Locations: The Clinical and Translational Research Center Chapel Hill, North Carolina, United States

View Trial Details

Completed

Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients

NCT01212614

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +5 more
Locations: University of Zurich Zurich, Switzerland

View Trial Details

Completed

Analysis of Biopsies From the Upper Gastrointestinal Tract

NCT01576289

Conditions: Barrett Esophagus, Deglutition Disorders, Digestive System Diseases, +15 more
Locations: Medical University Graz, Austria

View Trial Details

Completed

Effect of Nortriptyline in Cortical Representation of Heartburn in Nonerosive Reflux Disease (NERD) Patients

NCT01065649

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +8 more
Locations: Kozma Passo Fundo, Rio Grande do Sul, Brazil

View Trial Details

Completed

Open-label Comparison of 24hr Gastric pH on Days 1, 2, 7 With Once-daily Administration of Lavoltidine 40 mg.

NCT00551473

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +5 more
Locations: GSK Investigational Site Randwick, Sydney, New South Wales, Australia

View Trial Details

Completed

Symptom Control and Impact on Daily Life in Patients With Gastroesophageal Reflux Disease

NCT01432392

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +4 more
Locations: Sofia, Bulgaria

Varna, Bulgaria

View Trial Details

Completed

Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease

NCT00829738

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +4 more
Locations: Nycomed Deutschland GmbH Aachen, Germany

Nycomed Deutschland GmbH Aachen, Germany

Nycomed Deutschland GmbH Ahrensburg, Germany

Nycomed Deutschland GmbH Alpenrod, Germany

View all 717 locations

View Trial Details

Completed

Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders

NCT00830115

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +13 more
Locations: Nycomed Deutschland GmbH Aachen, Germany

Nycomed Deutschland GmbH Ahrensburg, Germany

Nycomed Deutschland GmbH Altenburg, Germany

Nycomed Deutschland GmbH Ansbach, Germany

View all 201 locations

View Trial Details

Completed

Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD)

NCT00561730

Conditions: Deglutition Disorders, Digestive System Diseases, Esophageal Diseases, +5 more
Locations: Nycomed Deutschland GmbH Aachen, Germany

Nycomed Deutschland GmbH Ahrensburg, Germany

Nycomed Deutschland GmbH Alfeld, Germany

Nycomed Deutschland GmbH Altenburg, Germany

View all 259 locations

View Trial Details